Navigation Links
Covance Decides to Pursue Its Original Preclinical Strategy in China
Date:9/29/2008

PRINCETON, N.J., Sept. 29 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) announced today that it will no longer pursue a 50-50 joint venture with WuXi Pharmatech to provide preclinical contract research services in China.

"We expect China will become an attractive region for outsourced drug development services over the longer-term. To seize this opportunity, we will pursue our original strategy to build our own world-class preclinical facility in the region and aggressively compete as the global market leader in a business we know very well. We plan to build a comprehensive preclinical capability that matches the high-quality facilities and scientific teams our clients have grown to trust in Europe and North America," said Joe Herring, Covance chairman and chief executive officer. "Once built, the preclinical facility will complement our existing Phase II/III clinical development, central laboratory and our new bioanalytical capability in China and allow us to enjoy the full financial benefits of further leveraging Covance's high- quality brand and drug development experience into Asia."

About Covance

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 9,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.

Statements contained in this press release, which are not historical facts, such as statements about the nature, scope and timing and benefits of the planned joint venture as well as the attractiveness of China for delivering outsourced discovery and development services, the growth of the China market and advantages of conducting preclinical research and develo
'/>"/>

SOURCE Covance Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call
2. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
3. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
4. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
5. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
6. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
7. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
8. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
9. Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies
10. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
11. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... new generation of ultrasmall transistors and more...led semiconducting nanowires are closer to reality...ue University and the University of California at ...to create nanowires with layers of different mater... which is a critical requirement for making effici...
(Date:11/25/2009)... ,, BOCA RATON, Fla., Nov. 25 ... Not so for BodyLogicMD. The nation,s largest and...ializing exclusively in medically supervised bioi...sicians in its network since November 2008 - fr...d more physician-owned centers, including one in P...
(Date:11/25/2009)...5 Ardea Biosciences, Inc...uart, Pharm.D., president and chief executive offi... Health Care Conference. , ,Presentation details ...Care Conference,Date: Tuesday, December 1, 20...e New York Palace Hotel, New York, NY,Webcast: ...
(Date:11/24/2009)...New York investment bank KTA Capital,s client Neur...6.7 mil convertible note private placement with a ... was arranged by KTA Capital as Neuren,s exclusive... New York (PRWEB) November 23, 2009 -- The i...LC ("KTA Capital") has announced that it...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...Call/ - Neptune Technologies &,Bioressources Inc. ...ced,operational and financial results for the fisc...February 29, 2008 and provided an update on recent...w by 22% in the three-month period ended February ...ebruary 28, 2007 and 29% in,the nine months ended ...
...-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS...egic,restructuring plan to significantly reduce it...ities that the Board and management believe are mo...This plan re-focuses,Vasogen,s resources on the de...any seeks alternatives to fund further development...
...14 ,ExlService Holdings, Inc. (Nasdaq: EXLS ), a ...nnounced that Rembert de Villa has joined as Head ...ervices offerings focus on,helping clients improve...analytics, streamlining and improving business pro...s. Under the banner of Transformation Services,Rem...
Other Biology Technology:Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones 2Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones 3Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones 4Vasogen Announces Implementation of Strategic Restructuring Plan 2Vasogen Announces Implementation of Strategic Restructuring Plan 3Vasogen Announces Implementation of Strategic Restructuring Plan 4Vasogen Announces Implementation of Strategic Restructuring Plan 5EXL Announces Appointment of Rembert de Villa as Head of Transformation Services 2EXL Announces Appointment of Rembert de Villa as Head of Transformation Services 3EXL Announces Appointment of Rembert de Villa as Head of Transformation Services 4
(Date:11/24/2009)...9) -- The Wildlife Conservation Society (WCS) anno...ning population of Siberian tigers has likely decl...ing and habitat loss. , WCS says the... needs to be done to protect remaining populations...report was released by the Siberian Tiger Monitori...
(Date:11/24/2009)...search on bacterial communities throughout six lar...poral patterns, suggesting that scientists could u...mate change in the polar regions. The study, publi... Academy of Sciences Early Edition, shows that ba...hronously over time, correlating with seasonal shi...
(Date:11/23/2009)... strain of the deadly superbug MRSAan infection-ca...sposes a far greater health threat than previously...ding to a study in the December issue of Emerging...ly picked up in fitness centers, schools, and othe...en of MRSA within hospitals, the report found. , ...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2Drinking milk in the morning may help stave off lunchtime hunger 8943 1Drinking milk in the morning may help stave off lunchtime hunger 8943 2Snoring Isn 26apos 3Bt Sexy LLC Launches Survey to Determine Extent of Drowsy Drivers on Land Sea and In The Air 49556 1Snoring Isn 26apos 3Bt Sexy LLC Launches Survey to Determine Extent of Drowsy Drivers on Land Sea and In The Air 49556 2WuXi PharmaTech Appoints Wei Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility Eric Gu as Vice Presid 12715 1WuXi PharmaTech Appoints Wei Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility Eric Gu as Vice Presid 12715 2
...cally reduced the amount a heavy drinker will cons....,Heavy-drinking smokers in a laboratory setting w...g varenicline compared to those taking a placebo, ...al Biological Psychiatry . , The group taking va...me Chantix, reported feeling fewer cravings for al...
...for generations their apparent ability to store f...rtionally fewer calories. , While it has long be...ble, a University of New South Wales (UNSW) resear...een one hormone oestrogen and its impact on fat ...e 6 to 11 percent more body fat than men. Studies ...
...he way that proteins fold is vital to ensuring the...rsity of Leeds have discovered this is a ,hit and ...rongly many times before they form the correct str...proteins carry out numerous functions and play a c...cells. Sheena Radford, Professor of Structural Mol...
Other Biology News:1 drug may help people both lay down the drink and put out the cigarette 2Why do women store fat differently from men? 2Unfolding 'nature's origami' 2
Mouse Anti-Aequorin Monoclonal Antibody, Unconjugated, Clone 2Q2147 from Abcam
Anti-Phosphotyrosine IgG Monoclonal Antibody, Alkaline Phosphatase Conjugated, Clone AD548 from Assay Designs/Stressgen Bioreagents
...A isomers are predominantly used for labeling prot...d for labeling peptides and nucleotides because th...t is often required in the conjugation processes. ...ng peptides and proteins. 6-TAMRA is predominately...
Chicken Anti-Lactate Dehydrogenase Antibody, Unconjugated from Immunology Consultants Laboratory, Inc.
Biology Products: